Colour enhancement

From PsychonautWiki
(Redirected from Color enhancement)
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
4-HO-MET
MDMA
25C-NBOMe
Experience:3-MeO-PCP - Extreme psychosis
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
DiPT
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
LSZ
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
THJ-018
Piracetam
DPT
MiPLA
2C-E
Phenethylamine (compound)
ΑMT
JWH-018
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Experience:800 seeds LSA - My First Trip Ever
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Pramiracetam
25N-NBOMe
Efavirenz
4-HO-DiPT
MiPT
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
DMT
LSM-775
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
TMA-6
Tree.jpgJapanese Garden by Anonymous
3-MeO-PCE
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Bufotenin
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
25I-NBOH
Omberacetam
Experience:4x 200ug tabs - You do not need to understand
Amanita muscaria
4-HO-EPT
LSA
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Methallylescaline
2C-C
Experience:250mg DXM - DXM Itch and Trip Report
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Psilocin
Oxiracetam
4-HO-DPT
4-HO-DET
DOM
4-AcO-DiPT
Experience:337mg DMT fumarate - A Day With DMT
3-MMC
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
2C-B
MDEA
4-AcO-MET
4-FA
LSD
Experience:120mg - Garden of The Gods
DOI
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience:2 tabs DOB - My DOB Nightmare
4-AcO-DMT
Mescaline
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
1P-ETH-LAD
2C-I
4-HO-MiPT
2C-P
DET
Experience:40mg - Brothermind and the Forest's Hand
PRO-LAD
Bromo-DragonFLY
Experience:4.5g - The Grand Introduction to Beauty and Fear
Ibogaine
1P-LSD
2C-T-21
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
6-APB
25D-NBOMe
Psilocybin mushrooms
25C-NBOH
4-HO-MPT
6-APDB
3C-E
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
5-MeO-DiBF
MPT
5-Hydroxytryptophan
2C-B-FLY
Cannabis
Experience:4-AcO-DMT + 200mg Pill
TMA-2
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
25B-NBOMe
Ayahuasca
Proscaline
5-MeO-DALT
DOC
Chameleon.jpgChameleon by Anonymous.
Allylescaline
Aniracetam
Βk-2C-B
Selective serotonin reuptake inhibitor
MET
2C-D
Experience:1000 Morning Glory seeds - Rediscovering the Self
2C-T-7
ETH-LAD
Pregabalin
4-AcO-MiPT
Paradise island by Xanny.jpgParadise island by Subsentience
AL-LAD
PARGY-LAD
5-MeO-DiPT
Experience:25mg 3-MeO-PCP - Enhanced film experience
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
2C-T-2
THJ-2201
4-AcO-DET
MDAI
Phenylpiracetam
EPT
Experience:4-HO-MiPT / A care free psychedelic getaway
Experience:BK-2C-B - Various experiences
DOB
5-MeO-MiPT
Coluracetam
MDA
Experience:1mg 25c-NBOMe - Experiment in my room
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
JWH-073
Experience:25mg Deschloroketamine - My first time orally dosing DCK
25B-NBOH
Experience:300µg LSD - Togetherness and the Silent Dusk
1B-LSD
Chur City in Switzerland.jpgChur, Switzerland by Naps284
ALD-52
Escaline
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Enhancement of colour rose.jpgRose by Chelsea Morgan
GABAergic hallucinogens
5F-PB-22
2C-H
Memantine
25I-NBOMe
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.